Lv1
60 积分 2025-04-03 加入
Comparing the predictive ability of portoatrial and portocaval gradient after transjugular intrahepatic portosystemic shunt creation for variceal rebleeding
9天前
已完结
Emergent rescue transjugular intrahepatic portosystemic shunt within 8 h improves survival in patients with refractory variceal bleed
9天前
已完结
Predictive power of portal pressure gradient remeasured shortly after transjugular intrahepatic portosystemic shunt
9天前
已完结
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS
9天前
已完结
End-procedural adherence to recommended hemodynamic targets does not improve the outcome of elective TIPS in patients with cirrhosis
10天前
已完结
Identification of optimal portal pressure decrease to control ascites while minimizing HE after TIPS: A multicenter study
10天前
已完结
Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohort
23天前
已完结
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study
23天前
已完结
Consecutive fecal microbiota transplantation for metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial
24天前
已完结
Pilot trials of oral betaine in participants with non-alcoholic fatty liver disease and elevated alanine aminotransferase
24天前
已完结
皖公网安备34019202002308
